drugset / Trial / NCT02254811

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

NCT02254811

Phase 2/3 Completed 116 enrolled University of Alberta University of Calgary · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

Delivery of FMT by upper route, including gastroscopy, nasogastric/ nasojejunal tube, and lower route, including retention enema, sigmoidoscopy, or colonoscopy have all been utilized successfully. Endoscopic delivery requires significant health care utilization and associated cost. Therefore, it is extremely desirable if FMT can be infused by a non invasive modality, which would significantly reduce patient discomfort, procedure related risks and health care costs, while offering similar efficacy to colonoscopic delivery in the range of 90%.

Timeline

Start
2014-09-18
Primary completion
2016-12-12
Completion
2017-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplant Other / unclassified Oral